Arun Kumar

Arun Kumar, Pamela L. Lutsey, Wendy L. St Peter, Jon C. Schommer, Jeremy R. Van't Hof, Abhijeet Rajpurohit, Joel F. Farley 2023. Comparative Effectiveness of Ticagrelor, Prasugrel, and Clopidogrel for Secondary Prophylaxis in Acute Coronary Syndrome: A Propensity Score-Matched Cohort Study Clinical Pharmacology & Therapeutics, 113 2, 401-411

Arun Kumar, Pamela L. Lutsey, Wendy L. St. Peter, Jon C. Schommer, Jeremy R. Van't Hof, Abhijeet Rajpurohit, Joel F. Farley 2023. Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention Clinical Pharmacology & Therapeutics, 113 2, 412-422

Arun Kumar, Pamela L. Lutsey, Wendy L. St. Peter, Jon C. Schommer, Jeremy R. Van't Hof, Abhijeet Rajpurohit, Joel F. Farley 2023. Prescription Patterns of P2Y12 Inhibitors Following Revascularization in the United States: 2013-2018 Clinical and Translational Science, ,

Young Eun Shin, Arun Kumar, Jeff Jianfei Guo 2023. Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021 Clinical Drug Investigation, 43 4, 289-298

Abimbola O Williams, Sirikan Rojanasarot, Alysha M McGovern, Arun Kumar 2022. A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications Journal of Comparative Effectiveness Research, 12 2, e220167

Meena N Murugappan, Sarah M Westberg, Stephen Contag, Tanya E Melnik, Arun Kumar, Abhijeet Rajpurohit, Katie Thorsness, Joel F Farley 2022. Maternal ADHD and Perinatal Prescription Stimulant Use Journal of Attention Disorders, 26 10, 1347-1356

Young Eun Shin, Arun Kumar, Monica Hwang, Martha Mackey, Wenchen Kenneth Wu 2022. Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated Thrombosis Clinical Drug Investigation, 42 12, 1075-1083

Farley, J. F., Kumar, A., & Urick, B. Y. 2019. Measuring adherence: a proof of concept study for multiple medications for chronic conditions in alternative payment models Pharmacy, 7(3), 81, ,

Farley, J. F., Kumar, A., Urick, B. Y., & Domino, M. E. 2019. Patient-centered Medical Homes and Preventive Service Use. American Journal of Managed Care American Journal of Managed Care, 25(5), e153-e159., ,

Kumar, A., Talwar, A., Farley, J. F., Muzumdar, J., Schommer, J. C., Balkrishnan, R., & Wu, W. 2019. Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis Journal of the American Heart Association, 8(10), e012184. ,

Devi, B. R., Syed-Abdul, S., Kumar, A., Iqbal, U., Nguyen, P. A., Li, Y. C. J., & Jian, W. S. 2015. mHealth: An updated systematic review with a focus on HIV/AIDS and tuberculosis long-term management using mobile phones Computer methods and programs in Biomedicine, 122(2), 257-265. ,

Praveen, K. G., and K. Arun 2013. Drug utilization and evaluation of HMG-co A reductase inhibitors in a tertiary care teaching hospital Indian Journal of Pharmacy Practice 6 (4) , ,

Kumar, A., Berg, H., Rivers, Z., Mandic, P. K., Yang, J., & Farley, J. F. 2021. Cost-Effectiveness Analysis of Pharmacogenetic Testing in Opioid Analgesia in Pediatric Population Undergoing Surgery Value in Health, 24, , S175

Kumar, A., Lutsey, P. L., Peter, W. S., Schommer, J. C., & Farley, J. F. 2021. Trends in Prescription of P2Y12 Inhibitors Following Revascularization in Coronary Heart Disease Value in Health, 24, , S76-S77

Kumar A, Wu W 2019. Health-Related Quality of Life of Stroke Survivors Compared to Non-Stroke Individuals among African Americans in the United States: A Nationally Representative Propensity Score Matched Analysis Value in Health, 22 , , S137

Li W, Kumar A, Muzumdar J, Wu W 2019. Association between Perceived Risk and Willingness to Pay Thresholds among Interventions for Common Diseases Value in Health, 22, , S263

Farley JF, Kumar A, Urick B, Domino ME 2018. Medical Home Enrollment and Quality of Care: Population Estimates from the U.S. Medical Expenditure Panel Survey Pharmacoepidemiology and Drug Safety , Vol. 27 , 443-443

Kumar, A., Wu, W., & Nili, M. 2016. Cost-Effectiveness of Apixaban (Novel Oral Anti-Coagulant) Compared with Conventional Therapy for Stroke Prophylaxis among Renal Impaired Patients with Atrial-Fibrillation from Perspective of Us Third-Party Payer Value in Health, 19(3), , A47

Nili, M., Wu, W., & Kumar, A 2016. Cost-effectiveness analysis of dulaglutide compared with insulin glargine add on to insulin lispro in treatment of type 2 diabetes: a us third-party payer perspective Value in Health, 19(3), , A203